ACUJJA
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Mar 2022)
What this means for you
This application is over — abandoned 07 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90058864
- Mark type
- Stylized text
- Filed
- 17 Jul 2020
- Published for opposition
- 08 Jun 2021
- Abandoned
- 07 Mar 2022
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use
- Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; scientific research and development; scientific laboratory services; medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Medical services; medical testing services; DNA screening and analysis services for medical purposes
Owner
- Sierra Oncology, Inc., Wilmington, DE, US
- Sierra Oncology, Inc., Vancouver, B.C., DE, US
Prosecution history
- 19 Oct 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Oct 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Oct 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 12 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jun 2021 — PUBLISHED FOR OPPOSITION
- 19 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED